Compounds > tosyllysine chloromethyl ketone

tosyllysine chloromethyl ketone and Neoplasms

tosyllysine chloromethyl ketone has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Khalfin, B; Nathan, I; Parola, AH; Shadrin, N; Shapira, MG; Uppalapati, L1

Other Studies

2 other study(ies) available for tosyllysine chloromethyl ketone and Neoplasms

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Serine protease inhibitors interact with IFN-γ through up-regulation of FasR; a novel therapeutic strategy against cancer.
    Experimental cell research, 2015, Jan-15, Volume: 330, Issue:2

    Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Drug Synergism; Fas Ligand Protein; fas Receptor; HeLa Cells; HT29 Cells; Humans; Interferon-gamma; Neoplasms; RNA, Messenger; Serine Endopeptidases; Serine Proteinase Inhibitors; Tosyllysine Chloromethyl Ketone; Tosylphenylalanyl Chloromethyl Ketone; Up-Regulation

2015